公司资料
Tyra Biosciences 股价、新闻与催化剂
- 股票代码:
- TYRA
- 交易所:
- NASDAQ
- 行业:
- Biopharma
- 所在地:
- United States
股票表现
26.05 USD (+1.40%)
收盘价
最后更新: 2026年8月21日
1.7B USD
市值
股价为何变动
As of Aug 21, 2026, TYRA closed up 1.40% at $26.05. No new same-company headline was identified in the current news window.
公司概览
业务概览
Tyra Biosciences is a precision-oncology company focused on FGFR and related kinase biology. The company is trying to build a targeted-therapy franchise around genetically defined cancers.
所在地与行业分类
Headquartered in the United States and listed on NASDAQ, Tyra sits in specialty oncology biotechnology.
商业模式特征
The company depends on clinical proof, molecule selectivity, and the possibility of creating a differentiated kinase platform.
生物医药行业定位
Tyra is a high-beta oncology name whose valuation is highly sensitive to early clinical data.
未来催化剂
- Tyra Biosciences's catalyst is TYRA-300, with FGFR3-driven bladder-cancer data and related FGFR updates likely to matter most. The market will care about whether the precision-oncology story stays differentiated.
近期新闻
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。